相关实验视频
Updated: Jul 10, 2025

13:07
A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
12.2K
[光疗在痴呆症护理中的应用]
Hsin-Feng Su1, Shu-Yi Huang2, Huei-Chuan Sung3
1PhD, RN, Assistant Professor, Graduate Institute of Long-Term Care, Tzu Chi University of Science and Technology, Taiwan, ROC.
Hu li za zhi The journal of nursing
|November 20, 2023
概括
光疗提供了一种非药物治疗方法来管理痴呆症症状,如睡眠障碍和抑郁症. 这种干预有助于调节昼夜节律,改善患者的福祉和护理质量.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 痴呆症经常表现为睡眠障碍,抑郁和行为症状.
- 传统的治疗方法,如抗精神病药物和身体限制,具有重大风险.
- 不药物干预越来越多地被推用于痴呆症症状管理.
研究的目的:
- 评估光疗作为痴呆症相关症状的第一线干预措施.
- 探索光疗在治疗痴呆症患者睡眠障碍和抑郁症方面的疗效.
- 突出护士在实施补充护理策略中的作用.
主要方法:
- 对痴呆症的非药物干预措施的元分析的审查.
- 专注于照明疗法的机制:补偿白天照明不足.
- 应用光疗来调节痴呆症患者的昼夜节律.
主要成果:
- 照明疗法在缓解与痴呆症相关的睡眠障碍和抑郁症方面表现有前途.
- 包括光疗在内的非药理学方法得到了元分析的支持.
- 通过补充干预措施改善患者治疗结果和护理质量的潜力.
结论:
- 光疗是一种可行的非药物选择,用于管理关键的痴呆症症状.
- 护士在评估患者需求和整合光疗方面发挥着至关重要的作用.
- 实施光疗可以提高痴呆症患者的整体护理和福祉.
更多相关视频
06:56Near Infrared NIr Light Increases Expression of a Marker of Mitochondrial Function in the Mouse Vestibular Sensory Epithelium
Published on: March 14, 2015
10.0K
08:16Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro
Published on: March 21, 2015
8.8K
相关概念视频
Dementia
117
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
117
Alzheimer's Disease: Treatment
196
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
196